BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2857256)

  • 1. Mycobacterium xenopi and BCG, pathogens of the future?
    Lancet; 1985 Jan; 1(8421):174-5. PubMed ID: 2857256
    [No Abstract]   [Full Text] [Related]  

  • 2. Human phagocyte oxidative burst activation by BCG, M. leprae, and atypical mycobacteria: defective activation by M. leprae is not reversed by interferon gamma.
    Launois P; Maillere B; Dieye A; Sarthou JL; Bach MA
    Cell Immunol; 1989 Nov; 124(1):168-74. PubMed ID: 2509079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The surfaces of colonies of Mycobacterium species studied in the scanning electron microscope].
    Putina TG; Pavlova IB
    Zh Mikrobiol Epidemiol Immunobiol; 1989 May; (5):3-8. PubMed ID: 2675500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular enzyme activities potentially involved in the pathogenicity of Mycobacterium tuberculosis.
    Raynaud C; Etienne G; Peyron P; Lanéelle MA; Daffé M
    Microbiology (Reading); 1998 Feb; 144 ( Pt 2)():577-587. PubMed ID: 9493394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A new method of determining the virulence of nontubercular mycobacteria and weakly virulent Mycobacterium tuberculosis].
    Bridnaia IuE; Amfiteatrova NF; Kalugina NM
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Nov; (11):9-12. PubMed ID: 3124419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The activity of transaminating enzymes in mycobacteria of different virulence].
    Aleb MO; Golyshevskaia VI
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Mar; 0(3):145. PubMed ID: 1092104
    [No Abstract]   [Full Text] [Related]  

  • 7. The pathogenicity and nomenclature of the mycobacteria.
    Francis J; Abrahams EW
    Tubercle; 1982 Dec; 63(4):309-10. PubMed ID: 6926786
    [No Abstract]   [Full Text] [Related]  

  • 8. [The incorporation of the labelled precursors of macromolecular compounds into the cells of pathogenic and saprophytic mycobacteria in the presence of Desoxon-1].
    Dermicheva SG; Dosanov KSh; Koronelli TV
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):19-20. PubMed ID: 7521553
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of coccoid ultrafine forms of mycobacteria in the transmission of the mycobacterial infection.
    Golyshevskaya VI
    Pneumoftiziologia; 1991; 40(4):11-3. PubMed ID: 1842499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pott's disease caused by Mycobacterium xenopi.
    Jones PG; Schrager MA; Zabransky RJ
    Clin Infect Dis; 1995 Nov; 21(5):1352. PubMed ID: 8589186
    [No Abstract]   [Full Text] [Related]  

  • 11. [Atypical mycobacteria and their pathogenicity for agricultural animals].
    Shchurevskiĭ VE; Ovdienko NP; Kadochkin AM
    Veterinariia; 1978 Apr; (4):32-5. PubMed ID: 418560
    [No Abstract]   [Full Text] [Related]  

  • 12. Fate of Mycobacterium tuberculosis & M. scrofulaceum in guinea pigs after intracisternal inoculation.
    Shriniwas ; Mahboobullah ; Bhujwala RA; Pal D; Kiran U; Tandon PN
    Indian J Med Res; 1983 Dec; 78():751-5. PubMed ID: 6425210
    [No Abstract]   [Full Text] [Related]  

  • 13. Capacity of mouse organs to arrest 35S-labeled Mycobacteria modified by infection.
    Tsukamura M; Mizuno S; Tsukamura S
    Jpn J Tuberc; 1967 Jul; 14(1):1-5. PubMed ID: 4966123
    [No Abstract]   [Full Text] [Related]  

  • 14. Disseminated Mycobacterium xenopi infection.
    Weinberg JR; Dootson G; Gertner D; Chambers ST; Smith H
    Lancet; 1985 May; 1(8436):1033-4. PubMed ID: 2859475
    [No Abstract]   [Full Text] [Related]  

  • 15. The pathogenic effects of Mycobacterium haemophilum in immunosuppressed albino mice.
    Abbott MR; Smith DD
    J Med Microbiol; 1980 Nov; 13(4):535-40. PubMed ID: 7431372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in-vitro activity of five fluoroquinolones against mycobacteria.
    Davies S; Sparham PD; Spencer RC
    J Antimicrob Chemother; 1987 May; 19(5):605-9. PubMed ID: 3112094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genomics of mycobacteria.
    Viale MN; Zumárraga MJ; Araújo FR; Zarraga AM; Cataldi AA; Romano MI; Bigi F
    Rev Sci Tech; 2016 Apr; 35(1):215-40. PubMed ID: 27217180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.
    Ru H; Liu X; Lin C; Yang J; Chen F; Sun R; Zhang L; Liu J
    Front Cell Infect Microbiol; 2017; 7():239. PubMed ID: 28642843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IMMUNOLOGIC RELATIONSHIPS BETWEEN TYPICAL AND ATYPICAL MYCOBACTERIA AS STUDIED BY MEANS OF THE MOUSE PROTECTION TEST.
    SIEBENMANN CO; BARBARA C
    Am Rev Respir Dis; 1964 Jan; 89():20-8. PubMed ID: 14114410
    [No Abstract]   [Full Text] [Related]  

  • 20. Haemolytic activity of Mycobacterium spp.
    Brzychcy M; Andrzejczyk Z; Zalewska N; Zwolska Z; Rudnicka W
    Acta Microbiol Pol; 1997; 46(4):377-85. PubMed ID: 9516984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.